Healthcare provider profile · identity verified

Efstratios Travlos, MD

Internal Medicine · DULUTH, MN · NPI 1457804544

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	653	56
Furosemide	Furosemide	450	42
Levothyroxine Sodium	Levothyroxine Sodium	406	25
Gabapentin	Gabapentin	398	44
Amlodipine Besylate	Amlodipine Besylate	344	33
Metoprolol Succinate	Metoprolol Succinate	307	30
Eliquis	Apixaban	299	23
Omeprazole	Omeprazole	294	34
Warfarin Sodium	Warfarin Sodium	290	12
Mirtazapine	Mirtazapine	275	15
Sertraline Hcl	Sertraline Hcl	273	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	192	22
Tamsulosin Hcl	Tamsulosin Hcl	177	17
Metformin Hcl	Metformin Hcl	172	22
Trazodone Hcl	Trazodone Hcl	164	25
Duloxetine Hcl	Duloxetine Hcl	149	17
Pantoprazole Sodium	Pantoprazole Sodium	149	18
Jardiance	Empagliflozin	129	14
Metoprolol Tartrate	Metoprolol Tartrate	122	21
Escitalopram Oxalate	Escitalopram Oxalate	112	suppressed
Potassium Chloride	Potassium Chloride	110	23
Baclofen	Baclofen	108	suppressed
Lisinopril	Lisinopril	99	25
Levetiracetam	Levetiracetam	97	suppressed
Xarelto	Rivaroxaban	96	suppressed
Clopidogrel	Clopidogrel Bisulfate	95	12
Losartan Potassium	Losartan Potassium	95	15
Hydralazine Hcl	Hydralazine Hcl	94	suppressed
Famotidine	Famotidine	93	14
Torsemide	Torsemide	93	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	91	22
Citalopram Hbr	Citalopram Hydrobromide	90	suppressed
Clonidine Hcl	Clonidine Hcl	88	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	73	suppressed
Spironolactone	Spironolactone	68	12
Bupropion Xl	Bupropion Hcl	66	suppressed
Methenamine Hippurate	Methenamine Hippurate	64	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	62	14
Carvedilol	Carvedilol	57	suppressed
Allopurinol	Allopurinol	54	suppressed
Novolog Flexpen	Insulin Aspart	50	14
Aripiprazole	Aripiprazole	49	suppressed
Lactulose	Lactulose	49	suppressed
Buspirone Hcl	Buspirone Hcl	48	suppressed
Nystatin	Nystatin	47	23
Prednisone	Prednisone	47	11
Pravastatin Sodium	Pravastatin Sodium	43	suppressed
Divalproex Sodium	Divalproex Sodium	41	suppressed
Finasteride	Finasteride	40	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	40	18
Simvastatin	Simvastatin	39	suppressed
Insulin Aspart Flexpen	Insulin Aspart	37	11
Diclofenac Sodium	Diclofenac Sodium	35	11
Donepezil Hcl	Donepezil Hcl	35	suppressed
Fluticasone Propionate	Fluticasone Propionate	35	12
Tramadol Hcl	Tramadol Hcl	35	17
Carbidopa-Levodopa	Carbidopa/Levodopa	34	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	34	28
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Glipizide	Glipizide	32	suppressed
Labetalol Hcl	Labetalol Hcl	31	suppressed
Creon	Lipase/Protease/Amylase	30	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Humalog Kwikpen U-100	Insulin Lispro	30	suppressed
Ozempic	Semaglutide	30	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	29	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	29	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	14
Sotalol	Sotalol Hcl	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	16
Hydrochlorothiazide	Hydrochlorothiazide	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	14
Risperidone	Risperidone	25	suppressed
Trulicity	Dulaglutide	24	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	23	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	suppressed
Atenolol	Atenolol	22	suppressed
Divalproex Sodium Er	Divalproex Sodium	22	suppressed
Erythromycin	Erythromycin Base	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	20	suppressed
Digoxin	Digoxin	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Enulose	Lactulose	18	suppressed
Metformin Hcl Er	Metformin Hcl	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Nyamyc	Nystatin	17	11
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	15	13
Klayesta	Nystatin	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Nystop	Nystatin	15	12
Cephalexin	Cephalexin	14	suppressed
Cholestyramine	Cholestyramine (With Sugar)	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Victoza 2-Pak	Liraglutide	14	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Eplerenone	Eplerenone	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Valsartan	Valsartan	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	12	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Norethindrone Acetate	Norethindrone Acetate	11	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	11	suppressed
Perphenazine	Perphenazine	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error